NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.

about

Dasatinib promotes TRAIL-mediated apoptosis by upregulating CHOP-dependent death receptor 5 in gastric cancer.

P2860

Q54111073-4F4B90B1-BE24-4F43-82E5-3F8079E97479

P2860

NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.

Item

http://www.wikidata.org/entity/Q38631124

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

NKG2D gene polymorphisms are a ...... myeloid leukemia by dasatinib.

@en

type

Item

label

NKG2D gene polymorphisms are a ...... myeloid leukemia by dasatinib.

@en

prefLabel

NKG2D gene polymorphisms are a ...... myeloid leukemia by dasatinib.

@en

P1476

NKG2D gene polymorphisms are a ...... myeloid leukemia by dasatinib

@en

P2093

Daisuke Ohgiya

http://www.w3.org/2001/XMLSchema#string

Eri Kikkawa

http://www.w3.org/2001/XMLSchema#string

Erika Matsusita

http://www.w3.org/2001/XMLSchema#string

Hiromichi Matsushita

http://www.w3.org/2001/XMLSchema#string

Hiromichi Murayama

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kawada

http://www.w3.org/2001/XMLSchema#string

Ken Ohmachi

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Ando

http://www.w3.org/2001/XMLSchema#string

Ryujiro Hara

http://www.w3.org/2001/XMLSchema#string

Shinichiro Machida

http://www.w3.org/2001/XMLSchema#string

P2860

Large granular lymphocytosis during dasatinib therapy

Structural and Energetic Mechanisms of Cooperative Autoinhibition and Activation of Vav1

Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).

A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia.

Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-induced microclusters and is essential in T cell development and activation

The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing

Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors

NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial.

P2888

s12185-017-2294-1

P304

666-674

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-017-2294-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Makoto Onizuka

P577

2017-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091104640

http://www.w3.org/2001/XMLSchema#string

P698

28795321

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.

about

P2860

P2860

NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921